Vaccines to curb F&P Healthcare sales

Vaccines to curb F&P Healthcare sales
Dan Brunskill
Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

More Markets

Chorus' four-year revenue cap set at $4.1b
Markets

Chorus' four-year revenue cap set at $4.1b

ComCom says it has saved consumers $172.6m over the past four years.

Todd Corporation: the reset
Finance

Todd Corporation: the reset

Legacy gas assets will give way to a focus on solar electricity generation.

Kiwibank won't bring banking Revolut-ion
Finance

Kiwibank won't bring banking Revolut-ion

Forget Kiwibank. Revolut is the force big banks will have to reckon with, expert says.